Filing Details
- Accession Number:
- 0001209191-11-031298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-26 17:49:32
- Reporting Period:
- 2011-05-25
- Filing Date:
- 2011-05-26
- Accepted Time:
- 2011-05-26 16:49:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197032 | F Ian Smith | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-25 | 4,544 | $55.52 | 35,333 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-25 | 7,540 | $56.21 | 27,793 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,050 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $55.52 (range $55.07 to $55.98).
- Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $56.21 (range $56.00 to $56.63).
Billionaire Hedge Funds
